Literature DB >> 21274825

Methylphenidate in depersonalization disorder: a case report.

Q Foguet1, M J Alvárez, E Castells, F Arrufat.   

Abstract

The symptom of depersonalization is frequently associated with other mental disorders, physiological effects of substances or medical diseases. However, it is rare that, as in the case presented, the experiences of depersonalization form an isolated entity, a primary depersonalization disorder. Among the many psychoactive drugs studied, none of them has been shown to be the treatment of choice. Among those with which the best results are obtained are opioid receptor antagonists (naloxone and naltrexone), the combination of selective serotonin reuptake inhibitors with lamotrigine and clorimipramine. Although with virtually no evidence, we are presenting a case that responded spectacularly to methylphenidate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21274825

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  3 in total

1.  A Case of Depersonalization with Treatment-resistant Depression Successfully Treated with Sertraline-lamotrigine Combination.

Authors:  H Belli; M Akbudak; C Ural; D Aslaner
Journal:  West Indian Med J       Date:  2014-03-17       Impact factor: 0.171

2.  Use of Mixed Amphetamine Salts in a Patient with Depersonalization/Derealization Disorder.

Authors:  Samuel R Weber
Journal:  Innov Clin Neurosci       Date:  2020-01-01

3.  Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD).

Authors:  Eli Somer; Taryn Amos-Williams; Dan J Stein
Journal:  BMC Psychol       Date:  2013-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.